Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott T. Rottinghaus currently holds 21,792 shares of ENANTA PHARMACEUTICALS INC (ENTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott T. Rottinghaus has been a net seller of ENTA stock. They have purchased $0 and sold $207.2K worth of shares.
Scott T. Rottinghaus's most recent insider trade was on Dec 5, 2025, when they sold 798 shares at $14.23 per share.
Scott T. Rottinghaus serves as Executive at ENANTA PHARMACEUTICALS INC (ENTA). They have executed 15 insider transactions totaling $207.2K over their tenure at the company.
Scott T. Rottinghaus holds the position of Executive at ENANTA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Scott T. Rottinghaus has shown a selling trading pattern, with $0 in total purchases and $207.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Scott T. Rottinghaus was on Jul 15, 2024, when they sold $91.8K worth of ENTA shares. This transaction involved 5,375 shares at $17.08 per share.
Scott T. Rottinghaus currently owns 21,792 shares of ENANTA PHARMACEUTICALS INC (ENTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott T. Rottinghaus's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott T. Rottinghaus has 15 Form 4 filings on record as an insider at ENANTA PHARMACEUTICALS INC.
Set alerts for Scott T. Rottinghaus and 40,000+ other insiders.